Meet Our Distinguished Steering Committee
Co-Chairs
Photis Beris, MDProfessor of Haematology
Chairman of the Department
of Haematology
National and Kapodistrian University
of Athens School of Medicine
Laiko University Hospital
Athens, Greece
Pierre Brissot, MDProfessor of Medicine
Liver Disease Department
University Hospital Pontchaillou
Rennes, France
Maria D. Cappellini, MDProfessor of Internal Medicine
University of Milan
Chief, Hereditary Anaemia Centre
Maggiore Hospital
Milan, Italy
Faculty
Miguel R. Abboud, MDProfessor of Pediatrics
Hematology-Oncology
Chairman, Department of Pediatrics and Adolescent Medicine
American University of Beirut Medical Center
Beirut, Lebanon
Haifa Kathrin Al-Ali, MDDirector
Department of Hematology/Oncology
University of Leipzig
Leipzig, Germany
Emanuele Angelucci, MDDepartment Director
Hematology / Medical Oncology
Ospedale Oncologico di Riferimento Regionale “Armando Businco”
Cagliari, Italy
Mariane de Montalembert, MDService de Pédiatrie
Hospital Necker
Paris, France
Amal El Beshlawy, MD, PhDProfessor
Pediatric Hematology
Faculty of Medicine
Cairo University
Cairo, Egypt
Mohsen Saleh Elalfy, MDHead of Hematology/Oncology Unit
Pediatric Hemostasis and Thrombosis/Hemoglobinopathy
Ain Shams University
Cairo, Egypt
Hatoon Ezzat, MBBS, FRCPC, ABIM, MScMedical Director
Hemoglobinopathy and Hemosiderosis Programs of British Columbia
Department of Medicine
Division of Hematology
University of British Columbia
Vancouver, British Columbia
Tom Ganz, PhD, MDProfessor of Medicine and
Pathology
David Geffen
School of Medicine,
University of California,
Los Angeles, CA
Norbert Gattermann, MD, PhDDepartment of Haematology,
Oncology and Clinical Immunology
Heinrich-Heine-University
Dusseldorf, Germany
Aristoteles A.N. Giagounidis, MD, PhDHead, Department of Hematology and Oncology
Marienhospital
Düsseldorf, Germany
Chaim Hershko, MDProfessor Emeritus
Shaare Zedek Medical Center
Jerusalem, Israel
Adlette C. Inati, MDHead, Division of
Pediatric Hematology-Oncology
Medical Director
Children's Center for Cancer and Blood Diseases
Rafik Hariri University Hospital
Beirut, Lebanon
Achille Iolascon, MD, PhDMedical Genetics Chair
University Federico II – Naples
CEINGE - Advanced Biotechnologies
Naples, Italy
Lanetta B. Jordan, MDAssociate Professor
University of Miami
Miller School of Medicine
Miami, Florida
Antonis Kattamis, MDDivision of Hematology-Oncology, Head
First Department of Pediatrics
University of Athens
'Agia Sofia' Children's Hospital
Athens Greece
Jong Wook Lee, MD, PhDProfessor
Department of Internal Medicine
St. Mary's Hospital
The Catholic University
of Korea
Seoul, Korea
Heather A. Leitch, MD, PhD, FRCPCHematologist
Department of Medicine, Division of Hematology
St. Paul’s Hospital
University of British Columbia
Vancouver, British Columbia, Canada
Kai-Hsin Lin, MDProfessor of Paediatrics
National Taiwan University
Hospital
Taipei, Taiwan
Khaled M. Musallam, MD, PhDClinical Research Associate
Internal Medicine
Ospedale Maggiore Policlinico
University of Milan
Milan, Italy
Clinical Research Associate
American University of Beirut Medical Center
Beirut, Lebanon
Dudley J. Pennell, MD, FRCP, FACC, FESCProfessor of Cardiology
National Heart and Lung Institute
London, England
Alberto Piperno, MDProfessor of
Internal Medicine
Department of Clinical
Medicine and Prevention
University of Milano-Bicocca
Monza, Italy
Bunchoo Pongtanakul, MDFaculty of Medicine
Division of Hematology and Oncology
Department of Pediatrics
Siriraj Hospital, Mahidol University
Bangkok, Thailand
John B. Porter, MA, MD, FRCPProfessor, Department of Haematology
University College London
London, United Kingdom
Alberto Roghi, MDDirector, CMR Unit
Department of Cardiology
Niguarda Ca'Granda Hospital
Milan, Italy
Tim St. Pierre, BSc, PhDProfessor
School of Physics
The University of Western Australia
Crawley, Australia
Ali T. Taher, MDProfessor
Department of Internal Medicine
American University of Beirut Medical Center
Beirut, Lebanon
Yasser Ahmed Mohammed Wali, MDProfessor and Head, Child Health Department
Sultan Qaboos University
Muscat, Oman
Patrick B. Walter, PhDStaff Scientist
Hematology/Oncology
Children's Hospital & Research Center Oakland
Oakland, California
Guenter Weiss, MDProfessor of Medicine
Department of Internal Medicine, Clinical Immunology, and Infectious Diseases
Medical University of Innsbruck
Innsbruck, Austria
John C. Wood, MD, PhDAssistant Professor
Keck School of Medicine of USC
Division of Cardiology
Childrens Hospital Los Angeles
Los Angeles, California
Su-Peng Yeh, MDDirector, Hematology and Oncology
China Medical University
Taichung, Taiwan
Disclosure Information
Haifa Kathrin Al-Ali, MD, has received consulting fees from Novartis Pharmaceuticals Corporation; conducted contracted research for Celgene GmbH; and received honoraria for scientific lectures from Celgene GmbH and Novartis Pharmaceuticals Corporation.
Emanuele Angelucci, MD, has received honoraria from Novartis Pharmaceuticals Corporation.
Photis Beris, MD, has received grant/research support from, is on the speakers bureau of, and is on the advisory board for Novartis Pharmaceuticals Corporation; and is a consultant for Vifor International. Prof. Beris has disclosed that he will not reference any unlabeled/unapproved uses of drugs or devices.
Pierre Brissot, MD, has received grant/research support from and is on the speakers bureau of Novartis Pharmaceuticals Corporation.
Maria D. Cappellini, MD, is a consultant for and on the speakers bureau of Novartis Pharmaceuticals Corporation. Prof. Cappellini has disclosed that she will not reference any unlabeled/unapproved uses of drugs or devices.
Mariane de Montalembert, MD, is on the advisory board for Novartis Pharmaceuticals Corporation. Dr. de Montalembert has disclosed that she will not reference any unlabeled/unapproved uses of drugs or devices.
Amal El Beshlawy, MD, PhD, is on the speakers bureau of Genzyme and Novartis Pharmaceuticals Corporation.
Mohsen Saleh Elalfy, MD, has disclosed no significant relationships.
Hatoon Ezzat, MBBS, FRCPC, ABIM, MSc, has received honoraria from Novartis Pharmaceuticals Corporation.
Tom Ganz, PhD, MD, has received grant/research support from Amgen Pharmaceuticals and Novartis Pharmaceuticals. He is a consultant for Xenon Pharmaceuticals; and is on the advisory board for Intrinsic LifeSciences LLC. He is a shareholder for Intrinsic LifeSciences LLC and Xenon Pharmaceuticals.
Norbert Gattermann, MD, PhD, is on the speakers bureau of and on the advisory boards for Novartis Pharmaceuticals Corporation and Pharmion Corporation. Prof. Gatterman has disclosed that he will not reference any unlabeled/unapproved uses of drugs or devices.
Aristoteles A.N. Giagounidis, MD, PhD, is on the speakers bureau of Celgene Corporation; is on advisory boards for Novartis Pharmaceuticals Corporation and Pharmion Corporation; and is a stock shareholder in Hoffmann-La Roche Inc.
Chaim Hershko, MD, has no significant relationships to disclose.
Adlette C. Inati, MD, has no significant relationships to disclose.
Achille Iolascon, MD, PhD, has no significant relationships to disclose.
Lanetta B. Jordan, MD, has served as a consultant for Novartis Pharmaceuticals Corporation.
Antonis Kattamis, MD,
Jong Wook Lee, MD, PhD,
Heather A. Leitch, MD, PhD, FRCPC, is a consultant for and on the speakers bureau of Novartis Pharmaceuticals Corporation.
Kai-Hsin Lin, MD, has disclosed no significant relationships.
Khaled M. Musallam, MD, PhD, has received honoraria from Novartis Pharmaceuticals Corporation.
Dudley J. Pennell, MD, FRCP, FACC, FESC, is on the advisory board for Astellas Pharma, Inc. and Novartis Korea.
Alberto Piperno, MD, has no significant relationships to disclose.
Bunchoo Pongtanakul, MD, has conducted contracted research for GlaxoSmithKline; and is on the speakers bureau for Novartis Oncology.
John B. Porter, MA, MD, FRCP, has received grant/research support from and is on the speakers bureau of Novartis Pharmaceuticals Corporation; and is a consultant for Genzyme Corporation, Resonance Health Ltd, and Novartis Pharmaceuticals Corporation.
Alberto Roghi, MD, is on the speakers bureau of Novartis Pharmaceuticals Corporation.
Tim St. Pierre, BSc, PhD, is a consultant for and a stock shareholder in Resonance Health Ltd.
Ali T. Taher, MD, is on the speakers bureau of and on the advisory board for Novartis Pharmaceuticals Corporation.
Yasser Ahmed Mohammed Wali, MD, has disclosed no significant relationships.
Patrick B. Walter, PhD, has conducted contracted research for Novartis Pharmaceuticals Corporation.
Dr. Walter has disclosed that his presentation will include a discussion of the off-label use of deferasirox and desferrioxamine combination therapy in transfusion-dependent thalassaemia.
Guenter Weiss, MD, has no significant relationships to disclose.
John C. Wood, MD, PhD, has received grant/research support from, is on the speakers bureau of, and is on the advisory board for Novartis Pharmaceuticals Corporation; and is on the advisory board for Apotex Inc.
Su-Peng Yeh, MD, has received consulting fees from Bristol-Myers Squibb.
,